Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥45,039 | ¥43,505 | ¥78,142 | ¥67,699 |
| % Growth | 3.5% | -44.3% | 15.4% | – |
| Cost of Goods Sold | ¥18,972 | ¥16,597 | ¥33,377 | ¥18,488 |
| Gross Profit | ¥26,067 | ¥26,908 | ¥44,765 | ¥49,211 |
| % Margin | 57.9% | 61.9% | 57.3% | 72.7% |
| R&D Expenses | ¥6,897 | ¥8,324 | ¥8,575 | ¥6,109 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥16,907 | ¥15,581 | ¥15,649 | ¥14,200 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | -¥5 | -¥2 |
| Operating Expenses | ¥23,804 | ¥23,905 | ¥24,219 | ¥20,307 |
| Operating Income | ¥2,263 | ¥3,003 | ¥20,541 | ¥28,902 |
| % Margin | 5% | 6.9% | 26.3% | 42.7% |
| Other Income/Exp. Net | -¥266 | -¥150 | ¥683 | -¥1,370 |
| Pre-Tax Income | ¥1,997 | ¥2,853 | ¥21,224 | ¥27,532 |
| Tax Expense | ¥910 | ¥1,343 | ¥5,176 | ¥7,624 |
| Net Income | ¥1,042 | ¥1,480 | ¥16,012 | ¥19,849 |
| % Margin | 2.3% | 3.4% | 20.5% | 29.3% |
| EPS | 8.65 | 12.29 | 132.97 | 164.84 |
| % Growth | -29.6% | -90.8% | -19.3% | – |
| EPS Diluted | 8.65 | 12.29 | 132.97 | 164.84 |
| Weighted Avg Shares Out | 120 | 120 | 120 | 120 |
| Weighted Avg Shares Out Dil | 120 | 120 | 120 | 120 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥300 | ¥186 | ¥142 | ¥122 |
| Interest Expense | ¥20 | ¥23 | ¥24 | ¥23 |
| Depreciation & Amortization | ¥4,481 | ¥5,021 | ¥4,735 | ¥4,149 |
| EBITDA | ¥6,502 | ¥7,899 | ¥25,983 | ¥31,704 |
| % Margin | 14.4% | 18.2% | 33.3% | 46.8% |